Bengaluru, May 15 -- The share of this company, which is a research-driven company focused on developing and manufacturing complex generics, with a strong presence in the US, Canada, and regulated markets, came into focus after strong Q4 segment performance.

With a market capitalization of Rs 4,831 crore, Senores Pharmaceuticals Ltd's shares on Friday made a day high of Rs 1,062 per share, up 11.2 percent from its previous day's close price of Rs 954.80 per share. The share of this company gave a negative return of 94 percent over the last year.

Results Overview

QoQ View: The revenue from operations grew by 2.3 percent to Rs 175 crore in Q4 FY26 from Rs 171 crore in Q3 FY26 (Dec 2025). EBIDT saw a slight decrease of 5.7 percent to Rs 4...